Michael Schmertzler
10 stock trades in the last 12 months, shares they bought or sold themselves (not grants or options).
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
The 3 newest of 10 trades
| Stock | Trade | Amount | Traded |
|---|---|---|---|
| Sell(10b5-1 plan) | $149K | Oct 14SEC filing | |
| Sell(10b5-1 plan) | $158K | Oct 7SEC filing | |
| Sell(10b5-1 plan) | $679K | Sep 17SEC filing |
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
Michael Schmertzler's companies
| Stock | Trades | Quality Score |
|---|---|---|
| 10 |
Alerts for Michael Schmertzler
Use this page
How to cite
Breakaway, Michael Schmertzler: Director at PTC Therapeutics (PTCT), Oct 16, 2026, getbreakaway.com/insiders/michael-schmertzler
Journalists: email support@getbreakaway.com for the data behind this page.